ENTITY

Encore Medical (EMI US)

2
Analysis
Health Care • United States
Encore Medical is a structural heart device company focused on the transcatheter closure of cardiac defects, developing, manufacturing, and marketing septal occlusion products. This offering primarily aims to finance U.S. clinical trials for stroke and migraine indications, building on existing international sales.
more
bullish•Encore Medical
•30 Sep 2026 10:11

IPO Databook: Encore Medical (EMI US) - Sep 2026

Encore Medical is a structural heart device company focused on transcatheter closure of cardiac defects, developing and marketing septal...

Share
bearish•Encore Medical
•17 Jul 2026 17:00

Encore Medical (EMI US): Synthetic Expert Call Transcript (17 Jul 2026)

Slick clinical pedigree but highly restricted OUS economics: While Encore’s technology boasts over 35,000 successful transcatheter defect closure...

Share
No more insights
x